In new research presented at EULAR 2020, researchers sought to determine whether patients with psoriasis who also have certain bone lesions may be at higher risk of developing psoriatic arthritis and...
A history of cigarette smoking is associated with increased risk of psoriasis in the general population, according to the results of a recent meta-analysis.
Patients with psoriasis and mental health comorbidities are more likely to report lower satisfaction with their clinicians that those who do not have mental health symptoms, according to the results of a...
Researchers conducted a retrospective cohort analysis of patients with psoriasis with and without exposure to IL-17is, with primary outcomes including 6-month and 1-year IBD incidence.
While it has been established that brodalumab is effective for treatment of moderate-to-severe plaque psoriasis through 52 weeks, its safety and efficacy over a longer period is unknown.
In a recent review, Sara Jiayang Li, BS, Lourdes M. Perez-Chada, MD, MMSc, and Joseph F. Merola, MD, MMSc, at the Brigham and Women’s Hospital, Harvard Medical School in Boston, MA conducted a literature...
Supplementation with fish oil and omega-3 polyunsaturated fatty acids (ω-3 PUFAs) could benefit patients with psoriasis, according to the results of a recent study.
Authors of a new study presented at the 2019 ACR/ARP Annual Meeting assessed whether high-dimensional flow cytometry profiling can distinguish patients with psoriasis and patients with PsA.
While anti-tumor necrosis factor (TNF) inhibitors are effective treatments for patients with several inflammatory diseases, they may be associated with new onset psoriatic eruptions or paradoxical worsening...
